HRT Financial’s Praxis Precision Medicines PRAX Stock Holding History

HRT Financial’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	+3,400	New	+$1.05M	﹤0.01%	2002

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HRT Financial's PRAX Position: Q2 2024 in Review

HRT Financial sold out of Praxis Precision Medicines (PRAX) in Q2 2024, closing a stake of 14,764 shares — an estimated $900K sold.

HRT Financial first reported a position in PRAX in Q3 2022 and held it in 3 quarters. The position peaked at $900K in Q1 2024. 113 funds tracked by Wall St. Rank hold PRAX as of Q2 2024.

HRT Financial reported no remaining Praxis Precision Medicines position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 14,764 Praxis Precision Medicines shares in Q2 2024, an estimated $900K.
HRT Financial first reported a position in Praxis Precision Medicines in Q3 2022 and held it in 3 quarters.
HRT Financial's Praxis Precision Medicines position peaked at $900K in Q1 2024.
113 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.